CareFusion Recalls ChloraPrep Antiseptic Applicators Due to Fungal Contamination
CareFusion 213, LLC is recalling ChloraPrep One-Step antiseptic applicators because fungal growth breached package integrity under labeled storage conditions.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class I, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death. Per the rubric, an FDA Class I classification mandates a severity score of at least 4.
Plain-English summary
CareFusion 213, LLC is recalling ChloraPrep One-Step 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution applicators. The product is distributed in 25-applicator cartons and is identified by NDC 054365-400-01 and Catalog Number 260400. The recall involves 11,115,774 cartons distributed nationwide in the USA and to several international locations including Singapore, Chile, Oman, Colombia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, and Brazil.
The recall was initiated because the product is being recalled because at labeled storage conditions of 30°C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity. The source text does not report any illnesses or injuries associated with this recall.
Healthcare facilities and consumers should check their inventory for the specific lot numbers and expiration dates listed in the official recall notice. If the product is found, it should be removed from use and returned to the distributor or manufacturer according to the instructions provided in the full recall documentation.
The recalled product
- Product
- ChloraPrep One-Step 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution -Clear, 0.10 fl. oz. (3ml) each, 25 applicators per carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, NDC 054365-400-01 Cat. No. 26040
- Manufacturer
- CareFusion 213, LLC
- Affected units
- 11,115,774
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot and Exp Date: 0008777
- 12/31/2022
- 0016325
- 0021072
- 1/31/2023
- 0027041
- 0030959
- 0031090
- 0044735
- 0048062
- 2/28/2023
- 0052110
- 0056365
- 0086148
- 0104864
- 3/31/2023
- 0192894
- 6/30/2023
- 8081571
- 3/31/2021
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by CareFusion 213, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · CareFusion 213, LLC
See all →- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePurPrep Povidone Iodine and Isopropyl Alcohol Applicators Recall
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Antiseptic Applicators Distributed Without Sterilization
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Applicators Recalled for Lack of Sterile Assurance
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Loss
FDA (Drugs) · 2026-07-08
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15